Taiho Pharmaceutical To Launch Generic Campto
This article was originally published in PharmAsia News
Executive Summary
Tokyo based drug maker Taiho Pharmaceutical will launch anticancer drug irinotecanin May. The injection products will come in 40 milligram and 100 milligram doses. The company obtained manufacturing and marketing approval Jan. 28. Taiho has set its oncology business as top propriety; however, generic drugs are the first in its oncology lineup. With hospitals increased use of diagnostic procedure combined payment systems, the company sees a strong demand for generic cancer drugs. (Click here for more - Japanese language